Status:
COMPLETED
Implementing a Decision Aid for Breast Cancer and DCIS Patients Deciding on Their Radiation Treatment.
Lead Sponsor:
Maastricht University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a pre-and post intervention study on the effect and implementation of an personalized decision aid for woman with breast cancer who face a decision on their radiation treatment.
Detailed Description
Rationale: Guidelines on breast cancer treatment show grey areas for some radiotherapy (RT) indications. In some recommendations the uncertainty is marked and deferred to sharing the final decision on...
Eligibility Criteria
Inclusion
- 18 years or older
- Female
- Doubtful indication of:
- Whole breast irradiation after lumpectomy for DCIS
- Whole breast irradiation after lumpectomy for low risk invasive BC (TOP-1 study)
- Boost dose in case of Breast Conserving Therapy
- Thoracic wall irradiation post mastectomy
Exclusion
- Metastasis
- Inability to speak and read Dutch. Inability to use internet access, either in the home or at a hospital facility.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2020
Estimated Enrollment :
403 Patients enrolled
Trial Details
Trial ID
NCT03375801
Start Date
October 1 2017
End Date
July 27 2020
Last Update
July 28 2020
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud UMC
Nijmegen, Gelderland, Netherlands, 6525 GA
2
MAASTRO-clinic
Maastricht, Limburg, Netherlands, 6229 ET
3
Maastricht University
Maastricht, Limburg, Netherlands
4
Academisch Medisch Centrum (AMC)
Amsterdam, North Holland, Netherlands, 1105 AZ